Algifor Dolo Duo 500mg/150mg
Algifor Dolo Duo 500mg/150mg is a medicine authorised by Swissmedic under authorisation number 67737. The authorisation holder is Verfora SA. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 12 January 2021 and the authorisation is valid without a time limit. ATC code N02BE51 places the medicine in the group Analgesics.
| Authorisation number | 67737 |
|---|---|
| Name | Algifor Dolo Duo 500mg/150mg |
| Full name | Algifor Dolo Duo 500mg/150mg, Filmtabletten |
| Authorisation holder | Verfora SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | N02BE51 |
| First authorisation | 12 January 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Algifor Dolo Duo 500mg/150mg, Filmtabletten | D | 12 January 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | N02BE51 | 01.01.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Algifor Dolo Duo 500mg/150mg authorised in Switzerland?
Yes. Algifor Dolo Duo 500mg/150mg is authorised by Swissmedic under authorisation number 67737, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Algifor Dolo Duo 500mg/150mg have?
Algifor Dolo Duo 500mg/150mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Algifor Dolo Duo 500mg/150mg?
The authorisation holder is Verfora SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.